The economics of pediatric formulation development for off-patent drugs

Abstract Background: Many drugs currently used in children have never been adequately studied in rigorous scientific trials. Although these medications can still be prescribed in the pediatric setting, they are considered “off-label” because they are not specifically approved for use in children. Th...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical therapeutics 2008-11, Vol.30 (11), p.2133-2145
Hauptverfasser:	Milne, Christopher-Paul, JD, Bruss, Jon B., MD
Format:	Artikel
Sprache:	eng
Schlagworte:	Biological and medical sciences Chemistry, Pharmaceutical - economics Chemistry, Pharmaceutical - methods Child clinical trials Clinical Trials as Topic Drug Industry - economics Drug Industry - methods Drugs, Generic - economics Drugs, Generic - therapeutic use Humans incentives Internal Medicine Medical Education Medical sciences pediatric Pediatrics - economics Pediatrics - methods Pharmacology. Drug treatments research and development
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!